Fulvestrant-ratiopharm 250 mg Injektionslösung in einer Fertigspritze
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Fulvestrant
Available from:
EMRA-MED Arzneimittel GmbH (3263935)
Dosage:
250 mg
Pharmaceutical form:
Injektionslösung in einer Fertigspritze
Composition:
Teil 1 - Injektionslösung in einer Fertigspritze; Fulvestrant (29658) 250 Milligramm
Administration route:
intramuskuläre Anwendung
Authorization status:
zugelassen
Authorization date:
2020-11-09
